MyFinsight
Home
About
Contact
Back
Income Statement
Arbutus Biopharma Corp (ABUS)
source: myfinsight.com
Download
Download image
Acuitas Therapeutics
Inc.-License
$591K
Alnylam
Pharmaceuticals Inc-Non Cash...
$526K
Qilu Pharmaceutical
Co LTD-License
$9,622K
Foreign exchange gain
(loss)
$21K
(362.50%↑ Y/Y)
Interest income
$1,042K
(-43.03%↓ Y/Y)
Revenues
$10,739K
(522.19%↑ Y/Y)
Total other income
$1,035K
(-42.08%↓ Y/Y)
Gain (loss) from
operations
$1,488K
(106.89%↑ Y/Y)
Interest expense
$28K
Total operating
expenses
$9,251K
(-60.31%↓ Y/Y)
Net income (loss)
$2,523K
(112.74%↑ Y/Y)
Change in fair value of
contingent consideration
$260K
(23.22%↑ Y/Y)
General and
administrative
$3,328K
(-55.90%↓ Y/Y)
Research and development
$5,498K
(-64.65%↓ Y/Y)
Restructuring costs
$165K
Comprehensive income (loss)
$2,502K
(112.68%↑ Y/Y)
Unrealized (loss) gain on
available-for-sale securities
-$21K
(-133.33%↓ Y/Y)
Back